Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 171 articles:
HTML format
Text format



Single Articles


    May 2017
  1. YAN J, Ma C, Gao Y
    MicroRNA-30a-5p suppresses epithelial-mesenchymal transition by targeting profilin-2 in high invasive non-small cell lung cancer cell lines.
    Oncol Rep. 2017;37:3146-3154.
    PubMed     Text format     Abstract available


  2. WANG J, Wang Y, Sun D, Ren F, et al
    CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017;37:3068-3074.
    PubMed     Text format     Abstract available


  3. CHEN G, Yu H, Satherley L, Zabkiewicz C, et al
    The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer.
    Oncol Rep. 2017;37:2695-2701.
    PubMed     Text format     Abstract available


  4. CAI Y, Ruan J, Yao X, Zhao L, et al
    MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.
    Oncol Rep. 2017;37:2787-2794.
    PubMed     Text format     Abstract available


    April 2017
  5. WANG W, Zhang L, Liu L, Zheng Y, et al
    Chemosensitizing effect of shRNA-mediated ERCC1 silencing on a Xuanwei lung adenocarcinoma cell line and its clinical significance.
    Oncol Rep. 2017;37:1989-1997.
    PubMed     Text format     Abstract available


  6. SHEN F, Long D, Yu T, Chen X, et al
    Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
    Oncol Rep. 2017;37:2481-2489.
    PubMed     Text format     Abstract available


  7. ZHANG R, Gu J, Chen J, Ni J, et al
    High expression of PINK1 promotes proliferation and chemoresistance of NSCLC.
    Oncol Rep. 2017;37:2137-2146.
    PubMed     Text format     Abstract available


    March 2017
  8. ZHANG L, Xiao X, An H, Wang J, et al
    Inhibition of CCR7 promotes NF-kappaB-dependent apoptosis and suppresses epithelial-mesenchymal transition in non-small cell lung cancer.
    Oncol Rep. 2017 Mar 23. doi: 10.3892/or.2017.5524.
    PubMed     Text format     Abstract available


  9. XIANG GL, Zhu XH, Lin CZ, Wang LJ, et al
    125I seed irradiation induces apoptosis and inhibits angiogenesis by decreasing HIF-1alpha and VEGF expression in lung carcinoma xenografts.
    Oncol Rep. 2017 Mar 23. doi: 10.3892/or.2017.5521.
    PubMed     Text format     Abstract available


  10. YANG N, Liang Y, Yang P, Ji F, et al
    Propofol suppresses LPS-induced nuclear accumulation of HIF-1alpha and tumor aggressiveness in non-small cell lung cancer.
    Oncol Rep. 2017 Mar 17. doi: 10.3892/or.2017.5514.
    PubMed     Text format     Abstract available


  11. SU J, Yan Y, Qu J, Xue X, et al
    Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-kappaB pathway.
    Oncol Rep. 2017;37:1565-1572.
    PubMed     Text format     Abstract available


  12. LI K, Yang M, Liang N, Li S, et al
    Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution (Review).
    Oncol Rep. 2017;37:1347-1358.
    PubMed     Text format     Abstract available


  13. CHOI YJ, Kim JH, Rho JK, Kim JS, et al
    AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis.
    Oncol Rep. 2017 Mar 1. doi: 10.3892/or.2017.5482.
    PubMed     Text format     Abstract available


  14. MA J, Li J, Yao X, Lin S, et al
    FIGNL1 is overexpressed in small cell lung cancer patients and enhances NCI-H446 cell resistance to cisplatin and etoposide.
    Oncol Rep. 2017 Mar 1. doi: 10.3892/or.2017.5483.
    PubMed     Text format     Abstract available


    February 2017
  15. CHEN S, Jiang S, Hu F, Xu Y, et al
    Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
    Oncol Rep. 2017 Feb 16. doi: 10.3892/or.2017.5461.
    PubMed     Text format     Abstract available


  16. GUO Y, Sun W, Gong T, Chai Y, et al
    miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5448.
    PubMed     Text format     Abstract available


  17. GUO CY, Yan C, Luo L, Goto S, et al
    Enhanced expression of PKM2 associates with the biological properties of cancer stem cells from A549 human lung cancer cells.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5438.
    PubMed     Text format     Abstract available


  18. KAKE S, Usui T, Ohama T, Yamawaki H, et al
    Death-associated protein kinase 3 controls the tumor progression of A549 cells through ERK MAPK/c-Myc signaling.
    Oncol Rep. 2017;37:1100-1106.
    PubMed     Text format     Abstract available


  19. CHEN T, Gong W, Tian H, Wang H, et al
    Fibroblast growth factor 18 promotes proliferation and migration of H460 cells via the ERK and p38 signaling pathways.
    Oncol Rep. 2017;37:1235-1242.
    PubMed     Text format     Abstract available


  20. KIM MH, Jeong YJ, Cho HJ, Hoe HS, et al
    Delphinidin inhibits angiogenesis through the suppression of HIF-1alpha and VEGF expression in A549 lung cancer cells.
    Oncol Rep. 2017;37:777-784.
    PubMed     Text format     Abstract available


  21. ZHANG B, Zhang Y, Yu D
    Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery.
    Oncol Rep. 2017;37:937-944.
    PubMed     Text format     Abstract available


  22. LIN D, Kuang G, Wan J, Zhang X, et al
    Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of beta-catenin expression.
    Oncol Rep. 2017;37:895-902.
    PubMed     Text format     Abstract available


    January 2017
  23. WANG J, Song J, Gao Z, Huo X, et al
    Analysis of gene expression profiles of non-small cell lung cancer at different stages reveals significantly altered biological functions and candidate genes.
    Oncol Rep. 2017 Jan 17. doi: 10.3892/or.2017.5380.
    PubMed     Text format     Abstract available


  24. LIU X, Wu X, Ma Y, Zhang W, et al
    Endophytic fungi from mangrove inhibit lung cancer cell growth and angiogenesis in vitro.
    Oncol Rep. 2017 Jan 16. doi: 10.3892/or.2017.5366.
    PubMed     Text format     Abstract available


  25. QIN Q, Wei F, Zhang J, Li B, et al
    miR-134 suppresses the migration and invasion of nonsmall cell lung cancer by targeting ITGB1.
    Oncol Rep. 2017 Jan 3. doi: 10.3892/or.2017.5350.
    PubMed     Text format     Abstract available


  26. ZHOU Y, Ma J, Zhang J, He L, et al
    Pifithrin-mu is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Oncol Rep. 2017;37:313-322.
    PubMed     Text format     Abstract available


  27. LI Z, Li B, Niu L, Ge L, et al
    miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9.
    Oncol Rep. 2017;37:297-304.
    PubMed     Text format     Abstract available


  28. GONG L, Zhou X, Yang J, Jiang Y, et al
    Effects of the regulation of polysialyltransferase ST8SiaII on the invasiveness and metastasis of small cell lung cancer cells.
    Oncol Rep. 2017;37:131-138.
    PubMed     Text format     Abstract available


    December 2016
  29. SHEN H, Wang L, Zhang J, Dong W, et al
    ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage response.
    Oncol Rep. 2016 Dec 28. doi: 10.3892/or.2016.5337.
    PubMed     Text format     Abstract available


  30. LEE YJ, Lim T, Han MS, Lee SH, et al
    Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells.
    Oncol Rep. 2016 Dec 23. doi: 10.3892/or.2016.5336.
    PubMed     Text format     Abstract available


  31. FUJIYOSHI K, Yamamoto G, Takahashi A, Arai Y, et al
    High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5323.
    PubMed     Text format     Abstract available


  32. XU J, Wu W, Wang J, Huang C, et al
    miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7.
    Oncol Rep. 2016 Dec 14. doi: 10.3892/or.2016.5314.
    PubMed     Text format     Abstract available


  33. WANG M, Wang Q, Peng WJ, Hu JF, et al
    Testin is a tumor suppressor in non-small cell lung cancer.
    Oncol Rep. 2016 Dec 14. doi: 10.3892/or.2016.5316.
    PubMed     Text format     Abstract available


  34. XIE S, Tu Z, Xiong J, Kang G, et al
    CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Oncol Rep. 2016 Dec 2. doi: 10.3892/or.2016.5289.
    PubMed     Text format     Abstract available


  35. ASAKA S, Yoshizawa A, Matsuda K, Yamaguchi A, et al
    A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens.
    Oncol Rep. 2016 Dec 2. doi: 10.3892/or.2016.5287.
    PubMed     Text format     Abstract available


  36. WEN R, Xiao Y, Zhang Y, Yang M, et al
    Identification of a novel transcript isoform of the TTLL12 gene in human cancers.
    Oncol Rep. 2016;36:3172-3180.
    PubMed     Text format     Abstract available


  37. LU X, Guo H, Chen X, Xiao J, et al
    Effect of RhoC on the epithelial-mesenchymal transition process induced by TGF-beta1 in lung adenocarcinoma cells.
    Oncol Rep. 2016;36:3105-3112.
    PubMed     Text format     Abstract available


    November 2016
  38. GU S, Zhang R, Gu J, Li X, et al
    HES5 promotes cellular proliferation of non-small cell lung cancer through STAT3 signaling.
    Oncol Rep. 2016 Nov 22. doi: 10.3892/or.2016.5268.
    PubMed     Text format     Abstract available


  39. LIU T, Yin H
    PDK1 promotes tumor cell proliferation and migration by enhancing the Warburg effect in non-small cell lung cancer.
    Oncol Rep. 2016 Nov 16. doi: 10.3892/or.2016.5253.
    PubMed     Text format     Abstract available


  40. KRASKO JA, Zilionyte K, Darinskas A, Strioga M, et al
    Bacterial ghosts as adjuvants in syngeneic tumour cell lysate-based anticancer vaccination in a murine lung carcinoma model.
    Oncol Rep. 2016 Nov 16. doi: 10.3892/or.2016.5252.
    PubMed     Text format     Abstract available


  41. KIM JH, Kim MS, Lee BH, Kim JK, et al
    Marmesin-mediated suppression of VEGF/VEGFR and integrin beta1 expression: Its implication in non-small cell lung cancer cell responses and tumor angiogenesis.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5245.
    PubMed     Text format     Abstract available


  42. WANG D, Ma J, Ji X, Xu F, et al
    miR-141 regulation of EIF4E expression affects docetaxel chemoresistance of non-small cell lung cancer.
    Oncol Rep. 2016 Nov 2. doi: 10.3892/or.2016.5214.
    PubMed     Text format     Abstract available


  43. XU L, Yan Y, Xue X, Li CG, et al
    Angiogenin elevates the invasive potential of squamous cell lung carcinoma cells through epithelialmesenchymal transition.
    Oncol Rep. 2016;36:2836-2842.
    PubMed     Text format     Abstract available


  44. JANG IS, Park JW, Jo EB, Cho CK, et al
    Growth inhibitory and apoptosis-inducing effects of allergen-free Rhus verniciflua Stokes extract on A549 human lung cancer cells.
    Oncol Rep. 2016;36:3037-3043.
    PubMed     Text format     Abstract available


  45. SHE K, Huang J, Zhou H, Huang T, et al
    lncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression.
    Oncol Rep. 2016;36:2673-2680.
    PubMed     Text format     Abstract available


  46. OLBROMSKI M, Grzegrzolka J, Jankowska-Konsur A, Witkiewicz W, et al
    MicroRNAs modulate the expression of the SOX18 transcript in lung squamous cell carcinoma.
    Oncol Rep. 2016;36:2884-2892.
    PubMed     Text format     Abstract available


  47. CHEN J, Lu X, Lu C, Wang C, et al
    13-Methyl-palmatrubine induces apoptosis and cell cycle arrest in A549 cells in vitro and in vivo.
    Oncol Rep. 2016;36:2526-2534.
    PubMed     Text format     Abstract available


    October 2016
  48. YAO J, Ma C, Gao W, Liang J, et al
    Fentanyl induces autophagy via activation of the ROS/MAPK pathway and reduces the sensitivity of cisplatin in lung cancer cells.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5183.
    PubMed     Text format     Abstract available


  49. CHEN X, Li Q, Kan XX, Wang YJ, et al
    Extract of Caulis Spatholobi, a novel blocker targeting tumor cellinduced platelet aggregation, inhibits breast cancer metastasis.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5184.
    PubMed     Text format     Abstract available


  50. LI G, He Y, Yao J, Huang C, et al
    Angelicin inhibits human lung carcinoma A549 cell growth and migration through regulating JNK and ERK pathways.
    Oncol Rep. 2016 Oct 12. doi: 10.3892/or.2016.5166.
    PubMed     Text format     Abstract available


  51. LIU Y, Miao L, Ni R, Zhang H, et al
    microRNA-520a-3p inhibits proliferation and cancer stem cell phenotype by targeting HOXD8 in non-small cell lung cancer.
    Oncol Rep. 2016 Oct 5. doi: 10.3892/or.2016.5149.
    PubMed     Text format     Abstract available


  52. CHEN YH, Zhou BY, Wu XJ, Xu JF, et al
    CCL22 and IL-37 inhibit the proliferation and epithelial-mesenchymal transition process of NSCLC A549 cells.
    Oncol Rep. 2016;36:2017-24.
    PubMed     Text format     Abstract available


  53. WANG X, Liu Y, Dai L, Liu Q, et al
    Foxp3 downregulation in NSCLC mediates epithelial-mesenchymal transition via NF-kappaB signaling.
    Oncol Rep. 2016;36:2282-8.
    PubMed     Text format     Abstract available


  54. ZHUANG X, Qiao T, Xu G, Yuan S, et al
    Combination of nadroparin with radiotherapy results in powerful synergistic antitumor effects in lung adenocarcinoma A549 cells.
    Oncol Rep. 2016;36:2200-6.
    PubMed     Text format     Abstract available


    September 2016
  55. PENG J, Liu HZ, Zhong J, Deng ZF, et al
    MicroRNA187 is an independent prognostic factor in lung cancer and promotes lung cancer cell invasion via targeting of PTRF.
    Oncol Rep. 2016 Sep 12. doi: 10.3892/or.2016.5083.
    PubMed     Text format     Abstract available


  56. ZHAO H, Xue J, Liu J, Liu Y, et al
    Effect of metastasis suppressor 1 on H1299 cells and its clinical significance in non-small cell lung cancer.
    Oncol Rep. 2016 Sep 12. doi: 10.3892/or.2016.5081.
    PubMed     Text format     Abstract available


  57. SHI H, Ji Y, Zhang D, Liu Y, et al
    MicroRNA-3666-induced suppression of SIRT7 inhibits the growth of non-small cell lung cancer cells.
    Oncol Rep. 2016 Sep 5. doi: 10.3892/or.2016.5063.
    PubMed     Text format     Abstract available


  58. UTHAISAR K, Vaeteewoottacharn K, Seubwai W, Talabnin C, et al
    Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity.
    Oncol Rep. 2016;36:1435-46.
    PubMed     Text format     Abstract available


  59. CHENG Q, Zhou L, Zhou J, Wan H, et al
    ACE2 overexpression inhibits acquired platinum resistance-induced tumor angiogenesis in NSCLC.
    Oncol Rep. 2016;36:1403-10.
    PubMed     Text format     Abstract available


  60. UGUEN A, Andrieu-Key S, Vergne F, Descourt R, et al
    ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues.
    Oncol Rep. 2016;36:1427-34.
    PubMed     Text format     Abstract available


  61. CHEN J, Hu L, Chen J, Wu F, et al
    Low expression lncRNA RPLP0P2 is associated with poor prognosis and decreased cell proliferation and adhesion ability in lung adenocarcinoma.
    Oncol Rep. 2016;36:1665-71.
    PubMed     Text format     Abstract available


    August 2016
  62. LIU L, Mei Q, Zhao J, Dai Y, et al
    Suppression of CEP55 reduces cell viability and induces apoptosis in human lung cancer.
    Oncol Rep. 2016 Aug 31. doi: 10.3892/or.2016.5059.
    PubMed     Text format     Abstract available


  63. ZHANG J, Yamada O, Kida S, Matsushita Y, et al
    Identification of brefelamide as a novel inhibitor of osteopontin that suppresses invasion of A549 lung cancer cells.
    Oncol Rep. 2016 Aug 5. doi: 10.3892/or.2016.5006.
    PubMed     Text format     Abstract available


  64. DU H, Huang Y, Hou X, Yu X, et al
    DT-13 inhibits cancer cell migration by regulating NMIIA indirectly in the tumor microenvironment.
    Oncol Rep. 2016;36:721-8.
    PubMed     Text format     Abstract available


  65. FAN Z, Jiang H, Wang Z, Qu J, et al
    Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-beta1 by attenuating the upregulation of SphK1.
    Oncol Rep. 2016;36:1016-22.
    PubMed     Text format     Abstract available


  66. WAN J, Wu W, Huang Y, Ge W, et al
    Incomplete radiofrequency ablation accelerates proliferation and angiogenesis of residual lung carcinomas via HSP70/HIF-1alpha.
    Oncol Rep. 2016;36:659-68.
    PubMed     Text format     Abstract available


  67. CHEN Q, Hu H, Jiao D, Yan J, et al
    miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
    Oncol Rep. 2016;36:909-17.
    PubMed     Text format     Abstract available


  68. BAO Z, Lu G, Cui D, Yao Y, et al
    IL-17A-producing T cells are associated with the progression of lung adenocarcinoma.
    Oncol Rep. 2016;36:641-50.
    PubMed     Text format     Abstract available


    July 2016
  69. XIONG J, Wu JS, Mao SS, Yu XN, et al
    Effect of saracatinib on pulmonary metastases from hepatocellular carcinoma.
    Oncol Rep. 2016 Jul 22. doi: 10.3892/or.2016.4968.
    PubMed     Text format     Abstract available


  70. HU P, He J, Liu S, Wang M, et al
    beta2-adrenergic receptor activation promotes the proliferation of A549 lung cancer cells via the ERK1/2/CREB pathway.
    Oncol Rep. 2016 Jul 22. doi: 10.3892/or.2016.4966.
    PubMed     Text format     Abstract available


  71. SUNG WJ, Kim H, Park KK
    The biological role of epithelial-mesenchymal transition in lung cancer (Review).
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4964.
    PubMed     Text format     Abstract available


  72. CHEN X, Wei L, Zhao S
    miR-338 inhibits the metastasis of lung cancer by targeting integrin beta3.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4928.
    PubMed     Text format     Abstract available


  73. OU Y, Ho WS
    Crocodile blood extract induces the apoptosis of lung cancer cells through PTEN activity.
    Oncol Rep. 2016 Jul 5. doi: 10.3892/or.2016.4914.
    PubMed     Text format     Abstract available


  74. WU HJ, Wu HB, Zhao YQ, Chen LJ, et al
    Bergamottin isolated from Citrus bergamia exerts in vitro and in vivo antitumor activity in lung adenocarcinoma through the induction of apoptosis, cell cycle arrest, mitochondrial membrane potential loss and inhibition of cell migration and invasion.
    Oncol Rep. 2016;36:324-32.
    PubMed     Text format     Abstract available


  75. WANG Z, Tang F, Hu P, Wang Y, et al
    HDAC6 promotes cell proliferation and confers resistance to gefitinib in lung adenocarcinoma.
    Oncol Rep. 2016;36:589-97.
    PubMed     Text format     Abstract available


  76. WANG J, Weng Y, Zhang M, Li Y, et al
    BMP9 inhibits the growth and migration of lung adenocarcinoma A549 cells in a bone marrow stromal cellderived microenvironment through the MAPK/ERK and NF-kappaB pathways.
    Oncol Rep. 2016;36:410-8.
    PubMed     Text format     Abstract available


  77. DUAN Q, Pang C, Chang N, Zhang J, et al
    Overexpression of PAD4 suppresses drug resistance of NSCLC cell lines to gefitinib through inhibiting Elk1-mediated epithelial-mesenchymal transition.
    Oncol Rep. 2016;36:551-8.
    PubMed     Text format     Abstract available


  78. LI JY, Yu J, Du XS, Zhang HM, et al
    Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway.
    Oncol Rep. 2016;36:147-54.
    PubMed     Text format     Abstract available


  79. KIM KH, Chae JI, Oh H, Cho JH, et al
    Manumycin A induces apoptosis in malignant pleural mesothelioma through regulation of Sp1 and activation of the mitochondria-related apoptotic pathway.
    Oncol Rep. 2016;36:117-24.
    PubMed     Text format     Abstract available


    June 2016
  80. YE H, Wei X, Wang Z, Zhang S, et al
    A novel double carbonyl analog of curcumin induces the apoptosis of human lung cancer H460 cells via the activation of the endoplasmic reticulum stress signaling pathway.
    Oncol Rep. 2016 Jun 30. doi: 10.3892/or.2016.4911.
    PubMed     Text format     Abstract available


  81. LIU M, Sun W, Liu Y, Dong X, et al
    The role of lncRNA MALAT1 in bone metastasis in patients with non-small cell lung cancer.
    Oncol Rep. 2016 Jun 29. doi: 10.3892/or.2016.4909.
    PubMed     Text format     Abstract available


  82. SUN Y, Han Y, Wang X, Wang W, et al
    Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer.
    Oncol Rep. 2016 Jun 23. doi: 10.3892/or.2016.4905.
    PubMed     Text format     Abstract available


  83. WEI XH, Lin SS, Liu Y, Zhao RP, et al
    DT-13 attenuates human lung cancer metastasis via regulating NMIIA activity under hypoxia condition.
    Oncol Rep. 2016 Jun 16. doi: 10.3892/or.2016.4879.
    PubMed     Text format     Abstract available


  84. GIANNINI R, Lupi C, Sensi E, Ali G, et al
    EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center.
    Oncol Rep. 2016 Jun 14. doi: 10.3892/or.2016.4874.
    PubMed     Text format     Abstract available


  85. ZHANG NH, Peng RQ, Ding Y, Zhang XS, et al
    Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells.
    Oncol Rep. 2016 Jun 13. doi: 10.3892/or.2016.4870.
    PubMed     Text format     Abstract available


  86. SHEN L, Yang M, Lin Q, Zhang Z, et al
    COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance.
    Oncol Rep. 2016 Jun 10. doi: 10.3892/or.2016.4869.
    PubMed     Text format     Abstract available


  87. JIN G, Jin M, Jin Z, Gao Z, et al
    Docetaxel-loaded PEG-albumin nanoparticles with improved antitumor efficiency against non-small cell lung cancer.
    Oncol Rep. 2016 Jun 8. doi: 10.3892/or.2016.4863.
    PubMed     Text format     Abstract available


  88. NAMBU J, Kobayashi T, Hashimoto M, Tashiro H, et al
    h-prune affects anaplastic thyroid cancer invasion and metastasis.
    Oncol Rep. 2016;35:3445-52.
    PubMed     Text format     Abstract available


  89. WU Y, Yu DD, Hu Y, Yan D, et al
    Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray.
    Oncol Rep. 2016;35:3371-86.
    PubMed     Text format     Abstract available


  90. HAN X, Tian Y, Tian D
    Tumor metastatic promoter ABCE1 interacts with the cytoskeleton protein actin and increases cell motility.
    Oncol Rep. 2016;35:3623-9.
    PubMed     Text format     Abstract available


    May 2016
  91. WANG J, Wan X, Gao Y, Zhong M, et al
    Latcripin-13 domain induces apoptosis and cell cycle arrest at the G1 phase in human lung carcinoma A549 cells.
    Oncol Rep. 2016 May 23. doi: 10.3892/or.2016.4830.
    PubMed     Text format     Abstract available


  92. HU CF, Huang YY, Wang YJ, Gao FG, et al
    Upregulation of ABCG2 via the PI3K-Akt pathway contributes to acidic microenvironment-induced cisplatin resistance in A549 and LTEP-a-2 lung cancer cells.
    Oncol Rep. 2016 May 23. doi: 10.3892/or.2016.4827.
    PubMed     Text format     Abstract available


  93. TU Z, He D, Deng X, Xiong M, et al
    An eight-long non-coding RNA signature as a candidate prognostic biomarker for lung cancer.
    Oncol Rep. 2016 May 18. doi: 10.3892/or.2016.4817.
    PubMed     Text format     Abstract available


  94. WAN Z, Jiang D, Chen S, Jiao J, et al
    T-box transcription factor brachyury promotes tumor cell invasion and metastasis in non-small cell lung cancer via upregulation of matrix metalloproteinase 12.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4792.
    PubMed     Text format     Abstract available


  95. ITO T, Ozaki S, Chanasong R, Mizutani Y, et al
    Activation of ERK/IER3/PP2A-B56gamma-positive feedback loop in lung adenocarcinoma by allelic deletion of B56gamma gene.
    Oncol Rep. 2016;35:2635-42.
    PubMed     Text format     Abstract available


  96. SUN M, Hong S, Li W, Wang P, et al
    MiR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4.
    Oncol Rep. 2016;35:2755-66.
    PubMed     Text format     Abstract available


  97. WANG X, Liu Y, Liu X, Yang J, et al
    MiR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma.
    Oncol Rep. 2016;35:3115-21.
    PubMed     Text format     Abstract available


    April 2016
  98. JIANG ZB, Huang J, Xie C, Li X, et al
    Combined use of PI3K and MEK inhibitors synergistically inhibits lung cancer with EGFR and KRAS mutations.
    Oncol Rep. 2016 Apr 26. doi: 10.3892/or.2016.4770.
    PubMed     Text format     Abstract available


  99. QIAO WL, Hu HY, Shi BW, Zang LJ, et al
    Lentivirus-mediated knockdown of TSP50 suppresses the growth of non-small cell lung cancer cells via G0/G1 phase arrest.
    Oncol Rep. 2016 Apr 20. doi: 10.3892/or.2016.4763.
    PubMed     Text format     Abstract available


  100. FENG C, Liu X, Li X, Guo F, et al
    Zoledronic acid increases the antitumor effect of gefitinib treatment for non-small cell lung cancer with EGFR mutations.
    Oncol Rep. 2016 Apr 13. doi: 10.3892/or.2016.4741.
    PubMed     Text format     Abstract available


  101. LEE YS, Doonan BB, Wu JM, Hsieh TC, et al
    Combined metformin and resveratrol confers protection against UVC-induced DNA damage in A549 lung cancer cells via modulation of cell cycle checkpoints and DNA repair.
    Oncol Rep. 2016 Apr 11. doi: 10.3892/or.2016.4740.
    PubMed     Text format     Abstract available


  102. ANDREASEN S, Persson M, Kiss K, Homoe P, et al
    Genomic profiling of a combined large cell neuroendocrine carcinoma of the submandibular gland.
    Oncol Rep. 2016;35:2177-82.
    PubMed     Text format     Abstract available


  103. GUO B, Li X, Song S, Chen M, et al
    (-)-beta-hydrastine suppresses the proliferation and invasion of human lung adenocarcinoma cells by inhibiting PAK4 kinase activity.
    Oncol Rep. 2016;35:2246-56.
    PubMed     Text format     Abstract available


  104. WANG Y, Han R, Chen Z, Fu M, et al
    A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database.
    Oncol Rep. 2016;35:2257-69.
    PubMed     Text format     Abstract available


    March 2016
  105. LI J, Guan J, Long X, Wang Y, et al
    mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance.
    Oncol Rep. 2016 Mar 29. doi: 10.3892/or.2016.4714.
    PubMed     Text format     Abstract available


  106. ZHOU L, Di Q, Sun B, Wang X, et al
    MicroRNA-194 restrains the cell progression of non-small cell lung cancer by targeting human nuclear distribution protein C.
    Oncol Rep. 2016 Mar 28. doi: 10.3892/or.2016.4708.
    PubMed     Text format     Abstract available


  107. WANG R, Ma L, Weng D, Yao J, et al
    Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Oncol Rep. 2016 Mar 17. doi: 10.3892/or.2016.4690.
    PubMed     Text format     Abstract available


  108. SHI S, Tan P, Yan B, Gao R, et al
    ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells.
    Oncol Rep. 2016 Mar 16. doi: 10.3892/or.2016.4680.
    PubMed     Text format     Abstract available


  109. SHEN L, Yang M, Lin Q, Zhang Z, et al
    SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer.
    Oncol Rep. 2016 Mar 10. doi: 10.3892/or.2016.4670.
    PubMed     Text format     Abstract available


  110. DA C, Liu Y, Zhan Y, Liu K, et al
    Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-beta1/Smad3 signaling pathway.
    Oncol Rep. 2016 Mar 7. doi: 10.3892/or.2016.4661.
    PubMed     Text format     Abstract available


  111. REN B, Wei X, Zou G, He J, et al
    Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer.
    Oncol Rep. 2016 Mar 1. doi: 10.3892/or.2016.4645.
    PubMed     Text format     Abstract available


    February 2016
  112. ZHANG W, Liang Z, Li J
    Inhibition of rhotekin exhibits antitumor effects in lung cancer cells.
    Oncol Rep. 2016 Feb 24. doi: 10.3892/or.2016.4634.
    PubMed     Text format     Abstract available


  113. XU YZ, Li YH, Lu WJ, Lu K, et al
    YL4073 is a potent autophagy-stimulating antitumor agent in an in vivo model of Lewis lung carcinoma.
    Oncol Rep. 2016 Feb 1. doi: 10.3892/or.2016.4603.
    PubMed     Text format     Abstract available


  114. HE Z, Huang C, Lin G, Ye Y, et al
    siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells.
    Oncol Rep. 2016 Feb 1. doi: 10.3892/or.2016.4602.
    PubMed     Text format     Abstract available


    January 2016
  115. LI M, Li JJ, Gu QH, An J, et al
    EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation.
    Oncol Rep. 2016 Jan 21. doi: 10.3892/or.2016.4587.
    PubMed     Text format     Abstract available


  116. WANG Y, Kong H, Zeng X, Liu W, et al
    Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells.
    Oncol Rep. 2016 Jan 18. doi: 10.3892/or.2016.4569.
    PubMed     Text format     Abstract available


  117. TIAN W, Liu J, Pei B, Wang X, et al
    Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer.
    Oncol Rep. 2016 Jan 14. doi: 10.3892/or.2016.4561.
    PubMed     Text format     Abstract available


  118. KONG R, Feng J, Ma Y, Zhou B, et al
    Silencing NACK by siRNA inhibits tumorigenesis in non-small cell lung cancer via targeting Notch1 signaling pathway.
    Oncol Rep. 2016 Jan 13. doi: 10.3892/or.2016.4552.
    PubMed     Text format     Abstract available


  119. WU TT, Lu CL, Lin HI, Chen BF, et al
    beta-Elemonic acid inhibits the cell proliferation of human lung adenocarcinoma A549 cells: The role of MAPK, ROS activation and glutathione depletion.
    Oncol Rep. 2016;35:227-34.
    PubMed     Text format     Abstract available


  120. ATZIN-MENDEZ JA, Lopez-Gonzalez JS, Baez R, Arenas-Del Angel MC, et al
    Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-beta2 microglobulin complexes.
    Oncol Rep. 2016;35:33-42.
    PubMed     Text format     Abstract available


    December 2015
  121. WAN J, Wu W, Zhang R
    Local recurrence of small cell lung cancer following radiofrequency ablation is induced by HIF1alpha expression in the transition zone.
    Oncol Rep. 2015 Dec 31. doi: 10.3892/or.2015.4541.
    PubMed     Text format     Abstract available


  122. SMARDOVA J, Liskova K, Ravcukova B, Malcikova J, et al
    Complex analysis of the p53 tumor suppressor in lung carcinoma.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4533.
    PubMed     Text format     Abstract available


  123. ZHAO W, Wang J, Zhu B, Duan Y, et al
    IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
    Oncol Rep. 2015 Dec 24. doi: 10.3892/or.2015.4516.
    PubMed     Text format     Abstract available


  124. MA L, Li P, Wang R, Nan Y, et al
    Analysis of novel microRNA targets in drug-sensitive and -insensitive small cell lung cancer cell lines.
    Oncol Rep. 2015 Dec 16. doi: 10.3892/or.2015.4487.
    PubMed     Text format     Abstract available


    November 2015
  125. YAKISICH JS, Azad N, Venkatadri R, Kulkarni Y, et al
    Digitoxin and its synthetic analog MonoD have potent antiproliferative effects on lung cancer cells and potentiate the effects of hydroxyurea and paclitaxel.
    Oncol Rep. 2015 Nov 12. doi: 10.3892/or.2015.4416.
    PubMed     Text format     Abstract available


  126. LI D, Du X, Liu A, Li P, et al
    Suppression of nucleosome-binding protein 1 by miR-326 impedes cell proliferation and invasion in non-small cell lung cancer cells.
    Oncol Rep. 2015 Nov 6. doi: 10.3892/or.2015.4403.
    PubMed     Text format     Abstract available


  127. ZHONG G, Chen X, Fang X, Wang D, et al
    Fra-1 is upregulated in lung cancer tissues and inhibits the apoptosis of lung cancer cells by the P53 signaling pathway.
    Oncol Rep. 2015 Nov 4. doi: 10.3892/or.2015.4395.
    PubMed     Text format     Abstract available


  128. XU C, Li S, Chen T, Hu H, et al
    miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
    Oncol Rep. 2015 Nov 4. doi: 10.3892/or.2015.4392.
    PubMed     Text format     Abstract available


  129. AQUINO-GALVEZ A, Gonzalez-Avila G, Delgado-Tello J, Castillejos-Lopez M, et al
    Effects of 2-methoxyestradiol on apoptosis and HIF-1alpha and HIF2alpha expression in lung cancer cells under normoxia and hypoxia.
    Oncol Rep. 2015 Nov 4. doi: 10.3892/or.2015.4399.
    PubMed     Text format     Abstract available


  130. JIANG F, Kuang B, Que Y, Lin Z, et al
    The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer.
    Oncol Rep. 2015 Nov 2. doi: 10.3892/or.2015.4373.
    PubMed     Text format     Abstract available


  131. BAHARUDDIN P, Satar N, Fakiruddin KS, Zakaria N, et al
    Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines.
    Oncol Rep. 2015 Nov 2. doi: 10.3892/or.2015.4371.
    PubMed     Text format     Abstract available


    October 2015
  132. LIU X, Qi D, Qi J, Mao Z, et al
    Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Oncol Rep. 2015 Oct 30. doi: 10.3892/or.2015.4365.
    PubMed     Text format     Abstract available


  133. XU W, Jiang K, Shen M, Chen Y, et al
    Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150.
    Oncol Rep. 2015 Oct 26. doi: 10.3892/or.2015.4349.
    PubMed     Text format     Abstract available


  134. MIN J, Li X, Huang K, Tang H, et al
    Phloretin induces apoptosis of non-small cell lung carcinoma A549 cells via JNK1/2 and p38 MAPK pathways.
    Oncol Rep. 2015 Oct 2. doi: 10.3892/or.2015.4325.
    PubMed     Text format     Abstract available


  135. HUNG MS, Chen IC, You L, Jablons DM, et al
    Knockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells.
    Oncol Rep. 2015 Oct 2. doi: 10.3892/or.2015.4324.
    PubMed     Text format     Abstract available


  136. LI Z, Wang Y, Kong L, Yue Z, et al
    Expression of ADAM12 is regulated by E2F1 in small cell lung cancer.
    Oncol Rep. 2015 Oct 1. doi: 10.3892/or.2015.4317.
    PubMed     Text format     Abstract available


    September 2015
  137. MA L, Wang R, Duan H, Nan Y, et al
    Mitochondrial dysfunction rather than mtDNA sequence mutation is responsible for the multi-drug resistance of small cell lung cancer.
    Oncol Rep. 2015 Sep 30. doi: 10.3892/or.2015.4315.
    PubMed     Text format     Abstract available


  138. LIN L, Lin H, Wang L, Wang B, et al
    miR-130a regulates macrophage polarization and is associated with non-small cell lung cancer.
    Oncol Rep. 2015 Sep 22. doi: 10.3892/or.2015.4301.
    PubMed     Text format     Abstract available


  139. WU L, Guo L, Liang Y, Liu X, et al
    Curcumin suppresses stem-like traits of lung cancer cells via inhibiting the JAK2/STAT3 signaling pathway.
    Oncol Rep. 2015 Sep 16. doi: 10.3892/or.2015.4279.
    PubMed     Text format     Abstract available


  140. JIN H, Qiao F, Wang Y, Xu Y, et al
    Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Oncol Rep. 2015 Sep 8. doi: 10.3892/or.2015.4258.
    PubMed     Text format     Abstract available


    August 2015
  141. SUN QF, Zhao XN, Peng CL, Hao YT, et al
    Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors.
    Oncol Rep. 2015 Aug 27. doi: 10.3892/or.2015.4231.
    PubMed     Text format     Abstract available


  142. XIAO X, Xiao Y, Wen R, Zhang Y, et al
    Promoting roles of the secreted frizzled-related protein 2 as a Wnt agonist in lung cancer cells.
    Oncol Rep. 2015 Aug 21. doi: 10.3892/or.2015.4221.
    PubMed     Text format     Abstract available


  143. LIM HS, Kang YJ, Sung B, Kim SH, et al
    Novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivative, MHY-449, induces cell cycle arrest and apoptosis via the downregulation of Akt in human lung cancer cells.
    Oncol Rep. 2015 Aug 19. doi: 10.3892/or.2015.4208.
    PubMed     Text format     Abstract available


  144. KUO WT, Tsai YC, Wu HC, Ho YJ, et al
    Radiosensitization of non-small cell lung cancer by kaempferol.
    Oncol Rep. 2015 Aug 19. doi: 10.3892/or.2015.4204.
    PubMed     Text format     Abstract available


  145. DONG DD, Zhou H, Li G
    ADAM15 targets MMP9 activity to promote lung cancer cell invasion.
    Oncol Rep. 2015 Aug 14. doi: 10.3892/or.2015.4203.
    PubMed     Text format     Abstract available


  146. LI F, Sun L, Zhang S
    Acquirement of DNA copy number variations in nonsmall cell lung cancer metastasis to the brain.
    Oncol Rep. 2015 Aug 10. doi: 10.3892/or.2015.4188.
    PubMed     Text format     Abstract available


  147. ZHU W, Liu J, Nie J, Sheng W, et al
    MG132 enhances the radiosensitivity of lung cancer cells in vitro and in vivo.
    Oncol Rep. 2015 Aug 4. doi: 10.3892/or.2015.4169.
    PubMed     Text format     Abstract available


    July 2015
  148. ZHAO C, Setrerrahmane S, Xu H
    Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line.
    Oncol Rep. 2015 Jul 30. doi: 10.3892/or.2015.4163.
    PubMed     Text format     Abstract available


  149. CHIANG IT, Wang WS, Liu HC, Yang ST, et al
    Curcumin alters gene expression-associated DNA damage, cell cycle, cell survival and cell migration and invasion in NCI-H460 human lung cancer cells in vitro.
    Oncol Rep. 2015 Jul 29. doi: 10.3892/or.2015.4159.
    PubMed     Text format     Abstract available


  150. ZHU J, Zeng Y, Xu C, Qin H, et al
    Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer.
    Oncol Rep. 2015 Jul 21. doi: 10.3892/or.2015.4141.
    PubMed     Text format     Abstract available


  151. HUANG W, Zhong W, Xu J, Su B, et al
    Lentivirus-mediated gene silencing of NOB1 suppresses non-small cell lung cancer cell proliferation.
    Oncol Rep. 2015 Jul 14. doi: 10.3892/or.2015.4132.
    PubMed     Text format     Abstract available


  152. WANG W, Sheng W, Yu C, Cao J, et al
    REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4121.
    PubMed     Text format     Abstract available


  153. WEI X, Dong J
    Aquaporin 1 promotes the proliferation and migration of lung cancer cell in vitro.
    Oncol Rep. 2015 Jul 3. doi: 10.3892/or.2015.4107.
    PubMed     Text format     Abstract available


    June 2015
  154. LV X, Liu F, Shang Y, Chen SZ, et al
    Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells.
    Oncol Rep. 2015 Jun 29. doi: 10.3892/or.2015.4091.
    PubMed     Text format     Abstract available


  155. SATO T, Soejima K, Arai E, Hamamoto J, et al
    Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.
    Oncol Rep. 2015 Jun 25. doi: 10.3892/or.2015.4082.
    PubMed     Text format     Abstract available


  156. YANG Y, Fan Y, Qi Y, Liu D, et al
    Side population cells separated from A549 lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic effect of cisplatin.
    Oncol Rep. 2015 Jun 12. doi: 10.3892/or.2015.4057.
    PubMed     Text format     Abstract available


  157. FAN Z, Duan X, Cai H, Wang L, et al
    Curcumin inhibits the invasion of lung cancer cells by modulating the PKCalpha/Nox-2/ROS/ATF-2/MMP-9 signaling pathway.
    Oncol Rep. 2015 Jun 9. doi: 10.3892/or.2015.4044.
    PubMed     Text format     Abstract available


  158. ZHANG C, Guo H, Li B, Sui C, et al
    Effects of Slit3 silencing on the invasive ability of lung carcinoma A549 cells.
    Oncol Rep. 2015 Jun 5. doi: 10.3892/or.2015.4031.
    PubMed     Text format     Abstract available


  159. GUO W, Zhang S, Liu S
    Establishment of a novel orthotopic model of breast cancer metastasis to the lung.
    Oncol Rep. 2015;33:2992-8.
    PubMed     Text format     Abstract available


    May 2015
  160. ZHANG X, Zheng L, Sun Y, Wang T, et al
    Tangeretin enhances radiosensitivity and inhibits the radiation-induced epithelial-mesenchymal transition of gastric cancer cells.
    Oncol Rep. 2015 May 15. doi: 10.3892/or.2015.3982.
    PubMed     Text format     Abstract available


  161. CHEN T, Gao F, Feng S, Yang T, et al
    MicroRNA-370 inhibits the progression of non-small cell lung cancer by downregulating oncogene TRAF4.
    Oncol Rep. 2015 May 13. doi: 10.3892/or.2015.3978.
    PubMed     Text format     Abstract available


  162. ZHANG X, Teng Y, Yang F, Wang M, et al
    MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
    Oncol Rep. 2015;33:2599-605.
    PubMed     Text format     Abstract available


  163. NAZIM UM, Jeong JK, Seol JW, Hur J, et al
    Inhibition of the autophagy flux by gingerol enhances TRAIL-induced tumor cell death.
    Oncol Rep. 2015;33:2331-6.
    PubMed     Text format     Abstract available


  164. TSUJI AB, Sugyo A, Sudo H, Suzuki C, et al
    Preclinical assessment of early tumor response after irradiation by positron emission tomography with 2-amino-[3-(1)(1)C]isobutyric acid.
    Oncol Rep. 2015;33:2361-7.
    PubMed     Text format     Abstract available


    April 2015
  165. PICKARSKI M, Gleason A, Bednar B, Duong LT, et al
    Orally active alphavbeta3 integrin inhibitor MK0429 reduces melanoma metastasis.
    Oncol Rep. 2015 Apr 9. doi: 10.3892/or.2015.3910.
    PubMed     Text format     Abstract available


  166. HIRATA T, Zheng Q, Chen Z, Kinoshita H, et al
    Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma.
    Oncol Rep. 2015;33:2052-60.
    PubMed     Text format     Abstract available


  167. TONG Y, Yue J, Mao M, Liu Q, et al
    Recombinant nematode anticoagulant protein c2 inhibits cell invasion by decreasing uPA expression in NSCLC cells.
    Oncol Rep. 2015;33:1815-22.
    PubMed     Text format     Abstract available


    March 2015
  168. WANG Z, Ma LJ, Kang Y, Li X, et al
    Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/beta-catenin pathway.
    Oncol Rep. 2015;33:1097-106.
    PubMed     Text format     Abstract available


    February 2015
  169. WOO JK, Kang JH, Jang YS, Ro S, et al
    Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment
    Oncol Rep. 2015 Feb 10. doi: 10.3892/or.2015.3793.
    PubMed     Text format     Abstract available


    January 2015
  170. YANG G, Li H, Yao Y, Xu F, et al
    Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
    Oncol Rep. 2015;33:478-84.
    PubMed     Text format     Abstract available


    November 2014
  171. SUN Y, Wang X, Zhou Q, Lu Y, et al
    Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo.
    Oncol Rep. 2014 Nov 3. doi: 10.3892/or.2014.3585.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: